2nd Quarter - Amendment

CAPITOL COUNSEL LLC for MERCK & COMPANY, INC.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2016 $60,000 Replaced
2nd Quarter - Amendment (this page) Oct 24, 2016 $30,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Pharmaceutical patent issues, including related provisions in H.R. 9, the Innovation Act, S. 1137, the PATENT Act, and H.R.3678, the Preserving Access to Orphan Drugs Act of 2015. Legislative issues related to the FDA Regulation of Biosimilars.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3678 (114th), S. 1137 (114th), H.R. 9 (114th)

Medicare/Medicaid MMM

Medicare Coverage and Reimbursement issues, including the CMS Part B Drug Demonstration Proposed Rule; Medicare access to DXA services; Medicare reimbursement for antimicrobial drugs, including related provisions in HR 512, The Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 512 (114th)

Health Issues HCR

Diabetes Prevention & Treatment, including related provisions of HR 2651, The Eliminating Disparities in Diabetes Prevention, Access and Care Act of 2013 and HR 1192, The National Diabetes Clinical Care Commission Act.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2651 (114th), H.R. 1192 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.